title: Maintenance treatment with inhaled ampicillin in patients with cystic fibrosis and lung infection due to methicillin-sensitive Staphylococcus aureus.
authors.forename: Luis
authors.initials: L
authors.lastname: Máiz
authors.forename: Rosa
authors.initials: R
authors.lastname: Del Campo
authors.forename: María
authors.initials: M
authors.lastname: Castro
authors.forename: Dayra
authors.initials: D
authors.lastname: Gutiérrez
authors.forename: Rosa
authors.initials: R
authors.lastname: Girón
authors.forename: Rafael
authors.initials: R
authors.lastname: Cantón Moreno
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000150:complications*; D004198:Disease Susceptibility; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006192:Haemophilus Infections / Q000150:complications; D044135:Haemophilus parainfluenzae / Q000302:isolation & purification; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D009330:Nebulizers and Vaporizers; D018410:Pneumonia, Bacterial / Q000150:complications; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D012189:Retrospective Studies; D015163:Superinfection / Q000382:microbiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000667:Ampicillin